PARLAR-02 Trial:Modified Transanal Drainage Tube Use for Preventing Anastomotic Leakage

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorThird Military Medical University

About this trial

Surgical resection remains the primary treatment for rectal cancer, but the postoperative incidence of anastomotic leakage (AL) is relatively high. AL not only increases the medical burden on patients, prolongs hospital stays, raises the need for secondary surgery, and elevates perioperative mortality, but also increases the long-term risk of local recurrence and reduces survival rates. There is an urgent need for a simple, effective treatment method that minimizes the burden on patients to prevent anastomotic leakage.

The preoperative placement of a transanal drainage tube (TDT) is believed to effectively drain gas and feces from the intestinal lumen, thereby reducing intestinal pressure and alleviating tension at the anastomotic site, thus preventing AL. Previous studies have shown that traditional drainage tubes cannot effectively prevent leakage. Given the limitations of existing research on traditional TDTs, we plan to use a modified TDT (which allows postoperative irrigation and utilizes a balloon to block feces from adversely affecting the anastomosis) to conduct a randomized, parallel-controlled trial. This study aims to further investigate the role of the modified TDT in preventing and treating anastomotic leakage following rectal surgery

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Rectal adenocarcinoma (confirmed by pathology);

Tumor location: The lower edge is ≤10 cm from the anal verge;

Age: ≥18 and ≤80 years old;

ASA ≤3 ;

Disqualifiers

Emergency surgery;

Presence of multiple primary colorectal cancers;

History of long - term use of immunosuppressants or corticosteroids;

Patients with severe mental illness or uncontrolled infection before surgery;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Modified Transanal Drainage Tube

    Device

    Patients with rectal adenocarcinoma will undergo elective laparoscopic/robotic low anterior resection. After the anastomosis is completed and the air leak test is confirmed to be negative, a modified TDT (occlusive balloon catheter) will be inserted. The balloon will be placed 5 cm above the anastomosis and filled under laparoscopic visualization (approximately 25 ml) to slightly dilate the intestinal lumen and occlude the intestinal cavity (under laparoscopic monitoring to ensure it does not affect the blood supply of the intestine). The external part of the tube will be sutured to the perianal skin and further secured with a 3M transparent dressing on the outside. It will be connected to a drainage bag (with an inner diameter greater than 8 mm) and left in place for 7 days, or until the drainage function is lost due to obvious defecation around the anal tube, at which point the catheter will be removed.

Treatment groups

968 Participants
are divided into 2 treatment groups
Group A: mTDT GroupExperimental treatment 1 intervention
Group B: Non-mTDT GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Incidence of AL

The incidence of total anastomotic leakage within 30 days after surgery

Time frame
The time frame is from the completion of the surgery to the 30th day after the surgery.

Secondary outcomes

1

Grades of AL

Classification of anastomotic leakage: Grade A is asymptomatic and detected by imaging only; Grade B requires specific interventions but not surgical treatment; Grade C requires surgical treatment.

Time frame
The time frame is from the completion of the surgery to the 30th day after the surgery.
2

Incidence of anastomosis-related complications

The overall incidence of anastomosis-related complications within 12 months after surgery.

Time frame
The time frame is from patient discharge to the 12th month after surgery.
3

3y-DFS AND LRR

Three-year disease-free survival (DFS) and local recurrence rate.

Time frame
The time frame is from patient discharge to the third year after surgery.
4

Perianal pain assessment score

Numerical Rating Scale (NRS) \[0-10 scale\]: No pain (0); Mild pain (1-3); Moderate pain (4-6); Severe pain (7-10)

Time frame
Measurement Time Points: Postoperative Day 1, Day 3, and Day 5

Other outcomes

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Army Medical Center (Daping Hospital)Recruiting400042, Yuzhong, Chongqing MunicipalityChinaChina

Sponsors and contacts

Click on the lead sponsor to view all of their trials.